How much funding has Generate Biomedicines raised?

Generate Biomedicines has raised $693.0M in total funding, most recently a Corporate Round.

Who are Generate Biomedicines's investors?

Generate Biomedicines's investors include Flagship Pioneering, Samsung Venture Investment Corporation, Abu Dhabi Investment Authority, T. Rowe Price, ARCH Venture Partners, Fidelity Management.

When was Generate Biomedicines founded?

Generate Biomedicines was founded in 2018.

Where is Generate Biomedicines headquartered?

Generate Biomedicines is headquartered in Cambridge, Massachusetts, United States.

What industry is Generate Biomedicines in?

Generate Biomedicines operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Generate Biomedicines have?

Generate Biomedicines has 201-500 employees.

Generate Biomedicines

IPO

Now we can.

Public · Cambridge, United States · Founded 2018 · $693.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2018
Business Model: B2B
Website: generatebiomedicines.com

Total Funding: $693.0M
Last Round: $273.0M Corporate RoundDec 2024
Rounds: 4
Type: Public

About

Generate Biomedicines is a therapeutics company pioneering Generative Biology — existing at the intersection of machine learning, biological engineering, and medicine. Their Generate Platform uses AI trained on 160,000 protein structures and 190 million genetic sequences to design novel protein-based therapeutics. The company aims to radically transform drug discovery by generating medicines rather than searching for them.

Summary

Generate Biomedicines is an Artificial Intelligence company based in Cambridge, United States, founded in 2018. It has raised $693.0M in total across 4 rounds, most recently a $273.0M Corporate Round round in Dec 2024. Investors include Flagship Pioneering, Samsung Venture Investment Corporation and Abu Dhabi Investment Authority.

LinkedIn X (Twitter)GitHub